NCT00064103View on ClinicalTrials.gov

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2007

Conditions
Lip and Oral Cavity CancerOropharyngeal CancerStage 0 Lip and Oral Cavity CancerStage 0 Oropharyngeal CancerTongue Cancer
Interventions
BIOLOGICAL

Ad5CMV-p53 gene

Given intramucosally or as oral rinse

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00064103 - Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx | Biotech Hunter | Biotech Hunter